D. Basart

发表

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

J. Witteman, E. Sijbrands, J. Kastelein, 2008, BMJ : British Medical Journal.

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Jennifer G. Robinson, J. D. Jordan, G. Molenberghs, 2016, Journal of the American Heart Association.

Abnormal hemostatic parameters in patients with myocardial infarction but angiographically normal coronary arteries.

S. Sivapalaratnam, M. Trip, G. Hovingh, 2014, International journal of cardiology.

Initial thyroid status and cardiovascular risk factors: The EPIC‐Norfolk prospective population study

R. Luben, N. Wareham, W. Wiersinga, 2010, Clinical endocrinology.

Comparison of transthoracic and transesophageal color Doppler flow imaging in patients with mechanical prostheses in the mitral valve position.

A. J. Dunning, C. Visser, R. V. D. van den Brink, 1989, The American journal of cardiology.

Evaluation of impedance plethysmography as a single non-invasive test for the diagnosis of clinically suspected deep vein thrombosis.

H. Büller, J. T. ten Cate, M. Huisman, 1984, The Netherlands journal of medicine.

Feasibility and Value of Transesophageal Echocardiography in Anesthetized Children

C. Visser, A. Nijveld, J. Schuller, 1989 .

A comparison of impedance plethysmography and strain gauge plethysmography in the diagnosis of deep venous thrombosis in symptomatic outpatients.

H. Büller, J. T. ten Cate, M. Huisman, 1985, Thrombosis research.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

J. Kastelein, M. Trip, A. Nederveen, 2012, European heart journal.

Prevention and Epidemiology

J. Kastelein, M. Trip, A. Nederveen, 2022 .

Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey.

E. Stroes, H. Kaasjager, D. Basart, 2010, The Netherlands journal of medicine.

Additional Efficacy of Milligram-Equivalent Doses of Atorvastatin over Simvastatin

M. Prins, M. Trip, J. Kastelein, 2000 .

High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study.

J. Kastelein, W. Spiering, B. Coll, 2013, Atherosclerosis.

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.

Leiv Ose, A. Zwinderman, M. Trip, 2009, JAMA.

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

G. Breithardt, H. Crijns, P. Mclaughlin, 2016, Journal of the American Heart Association.

Th e CETP inhibitor Torcetrapib and Off -target Toxicity A Pooled Analysis of the RADIANCE Trials.

D. Grobbee, M. Bots, G. Evans, 2008 .

The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.

S. Yusuf, M. Keltai, B. Lewis, 2000, European heart journal.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.